The EPO declined to attend the latest meeting organised by the Industry Patent Quality Charter, a group that has called on the office to grant higher-quality patents
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Panellists at a health policy roundtable dissected what the WHO’s latest pandemic treaty draft has to say about IP
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
The Munich local division was wrong to side with Amgen over the drugmaker’s failure to upload annexes to its infringement suit on time, the appeal court ruled
Judge Matthias Zigann said the panel wasn’t convinced that NanoString had infringed the 10x Genomics patent
The Ministry of Health has passed a resolution declaring public interest in the drug dolutegravir
Johnson & Johnson won’t enforce patents for bedaquiline after months of public scrutiny and new licences for generics
Civil society and industry representatives met in Geneva yesterday, September 28 to discuss a potential expansion of the TRIPS waiver
The decision marks the first time the Unified Patent Court has issued a preliminary injunction after an oral hearing involving both sides in a dispute
The drugmaker is reportedly accused of excessive pricing for anti-TB drug bedaquiline and patent evergreening
The UPC will decide whether to grant 10x Genomics a preliminary injunction against Nanostring on September 19
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyJianhui Li and Honghui Hu of Wanhuida Intellectual Property discuss the antitrust scrutiny of China’s Supreme People’s Court in a patent infringement appeal concerning reverse payment settlement agreement -
Sponsored by Purplevine IPXiaojuan Yu of Purplevine IP Group discusses the medical device industry in China and considers why changes to the law are welcomed
-
Sponsored by FB RiceLee Miles of FB Rice discusses Australia’s patent box scheme which is set to introduce the agricultural and low emissions technology sectors
-
Sponsored by Gün and PartnersBarış Kalaycı and Direnç Bada of Gün and Partners discuss an IP case that led to the discovery, and removal, of fake fire-resistant glass from hospitals in Turkey
-
Sponsored by Wanhuida Intellectual PropertyThe China Patent Office upheld the validity of the patent over the antihistamine desloratadine citrate disodium, as Yue Guan from Wanhuida Intellectual Property explains
-
Sponsored by Remfry & SagarShukadev Khuraijam and Ankush Verma of Remfry & Sagar discuss pre-grant straw man oppositions in India and the impact of a recent decision of the Bombay High Court
-
Sponsored by LexOrbisManisha Singh and Pradeep Kumar Kamal of LexOrbis explain how India has adopted a unique solution to protecting the rights of plant breeders and farmers
-
Sponsored by Gün and PartnersAysel Korkmaz Yatkın and Fatma Sevde Tan of Gün and Partners discuss a welcome decision that reinforces patent owners’ right to information about pharmaceutical licensing applications in Turkey
-
Sponsored by Wanhuida Intellectual PropertyXiaohui Wu, Yuming Wang and Jianhui Li of Wanhuida Intellectual Property discuss the Supreme People’s Court’s first decision in parallel civil and administrative proceedings involving a chiral drug patent
The bedaquiline case highlights why tools such as India’s pre-grant opposition mechanism are so important
Fatima Hassan, director of Health Justice Initiative, says IP office actions can yield major wins for patients and activists
Each week Managing IP speaks to a different IP lawyer about their life and career
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Interviews; Exclusives
Interviews; Exclusives
Counsel explain how they helped Eli Lilly overturn a damages award related to its migraine drug and why Supreme Court guidance proved useful
Samantak Ghosh, senior IP counsel at Gilead, talks about his pivot from research to law, the rise of biologics, and his pro bono work
Each week Managing IP speaks to a different IP lawyer about their life and career
Each week Managing IP speaks to a different IP lawyer about their life and career
Counsel at Sanofi reveal how they anticipated what questions US Supreme Court justices would throw at them and other challenges in the long-running case against Amgen
Alex Liu discusses the opportunities and challenges for pharma innovators in China and how he led his team to a record patent win
-
Weekly take: No harm in senators exploring patent alternatives
A proposed study into delinkage may not amount to much, and must be backed by strong evidence, but it can’t hurt to look into the issue -
Opinion: Indian domestic policy must match WTO stand on IP waivers
India has been both urging for vaccine waivers before the WTO and refusing compulsory licensing in the country, but it’s not helping anyone
In this special podcast, Managing IP talks to a charity that is working tirelessly to support mental health initiatives in the IP profession
In the latest episode of our monthly podcast, the team discusses law firm merger strategies, a high-profile break-up, and the latest 5G patent developments
In the latest episode of our monthly podcast, the team discusses their early memories of covering IP before delving into the latest on the UPC and whether a proposed US study could threaten the future of pharma patents
In the latest episode of our monthly podcast, the team discusses US and Asian approaches to the UPC, updates to trademark law in Japan and China, and the latest attempt at US patent reform
In the latest episode of our monthly podcast, the team joins you live from the Managing IP Intellectual Property & Innovation Summit in London, where SEPs and the UPC were both top of mind
In the third episode of our monthly podcast, the Managing IP editorial team unpacks SEP news, the probe into Judge Pauline Newman, and the biggest stories elsewhere
In the second episode of our monthly podcast, the Managing IP editorial team unpacks a busy month at SCOTUS, the EU’s solution to the FRAND conundrum, and the biggest stories elsewhere
In the first of a new monthly podcast, the Managing IP editorial team unpacks the race for the top job at the EUIPO, the key UPC trends to watch, and the biggest stories in Asian IP
Phyllis Turner-Brim talks about her career, the need for balance in intellectual property policy and her passion for diversity and inclusion
Derek Gilliland, who became a magistrate judge at the Western District of Texas this month, delves into his work, thoughts on Alan Albright and ambitions
